September 24, 2025
Labcorp and Natera have reached a midtrial settlement over the laboratory testing giant's claims that its competitor infringed a group of DNA sequencing patents through the sale of a cancer testing product, a Delaware federal judge said.
November 30, 2021
A Delaware federal judge has shot down attempts by several companies, including Natera Inc. and grocery startup Instacart, to invalidate the patent claims they are accused of infringing.
November 18, 2021
Delaware's Judge Leonard Stark on Monday will hold one of his "101 Day" hearings, where he considers patent eligibility fights and issues decisions on the same day, and one of the cases he's set to hear involves arguments from Natera Inc. looking to sink a DNA sequencing patent. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
May 10, 2021
Invitae, a genetic testing company based in San Francisco, has launched a lawsuit in Delaware federal court claiming that a non-invasive cancer detection test produced by rival Natera infringes an Invitae-owned DNA sequencing patent.